skip to main content
UK Health Security Agency

Proteus mirabilis

Proteus mirabilis

Catalogue No.

NCTC 14663

Current Name

Proteus mirabilis

Type Strain

Reference Strain

Culture Conditions

Growth Conditions on Solid Media

Columbia blood agar, 37oC, O2, 24 hours

Biological and Genomic Info

Strain Data

Positive for blaOXA-23 carbapenmase gene, although largely susceptible to carbapenem antibiotics. This is the first such isolate of blaOXA-23 positive proteus mirabilis identified by the ARMHAI.

Additional Info

Accession Date

11/03/2022

Depositor

K. Hopkins Antimicrobial Resistance & Mechanisms Service, Antimicrobial Resistance and Healthcare Associated Infections Unit, UK Health Security Agency, Colindale, London, UK)

Isolated From

Human (infection), urine. Norfolk and Norwich University Hospital (Norwich, UK). 06/11/2021.

History

Accessioned into NCTC < K. Hopkins < Isolated by Norfolk and Norwich University Hospital

Available Formats

  • Ampoule (Bacteria)

If use of this culture results in a scientific publication, it should be cited in the publication as: Proteus mirabilis (NCTC 14663)

It is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.